Celecoxib does not significantly delay bone healing in a rat femoral osteotomy model: a bone histomorphometry study

oxib does not significantly delay bone healing in a rat femoral osteotomy model: a bone histomorphometry study Original Research (2308) Total Article Views Authors: Iwamoto J, Seki A, Sato Y, Matsumoto H Published Date December 2011 Volume 2011:3 Pages 39 - 45 DOI: http://dx.doi.org/10.2147/ORR.S26848 Jun Iwamoto1, Azusa Seki2, Yoshihiro Sato3, Hideo Matsumoto1 1Institute for Integrated Sports Medicine, Keio University School of Medicine, Tokyo, Japan; 2Hamri Co, Ltd, Tokyo, Japan; 3Department of Neurology, Mitate Hospital, Fukuoka, Japan Background and objective: The objective of the present study was to determine whether celecoxib, a cyclo-oxygenase-2 inhibitor, would delay bone healing in a rat femoral osteotomy model by examining bone histomorphometry parameters. Methods: Twenty-one 6-week-old female Sprague-Dawley rats underwent a unilateral osteotomy of the femoral diaphysis followed by intramedullary wire fixation; the rats were then divided into three groups: the vehicle administration group (control, n = 8), the vitamin K2 administration (menatetrenone 30 mg/kg orally, five times a week) group (positive control, n = 5), and the celecoxib administration (4 mg/kg orally, five times a week) group (n = 8). After 6 weeks of treatment, the wires were removed, and a bone histomorphometric analysis was performed on the bone tissue inside the callus. The lamellar area relative to the bone area was significantly higher and the total area and woven area relative to the bone area were significantly lower in the vitamin K2 group than in the vehicle group. However, none of the structural parameters, such as the callus and bone area relative to the total area, lamellar and woven areas relative to the bone area, or the formative and resorptive parameters such as osteoclast surface, number of osteoclasts, osteoblast surface, osteoid surface, eroded surface, and bone formation rate per bone surface differed significantly between the vehicle and celecoxib groups. Conclusion: The present study implies that celecoxib may not significantly delay bone healing in a rat femoral osteotomy model based on the results of a bone histomorphometric analysis.